Skip to main content
Log in

Efficacy of Farabloc as an analgesic in primary fibromyalgia

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The goal of our study was to determine the efficacy of Farabloc, an electromagnetic shielding fabric compared to placebo fabric when worn as a nightgown, as an analgesic in patients hospitalized with fibromyalgia. In a rheumatologic and rehabilitation hospital, we performed a phase 1, single-blind study of patients using Farabloc (F) or placebo (P) gowns for 8 h per night during the 20-day hospitalization and a phase 2, single-blind crossover study of patients using both F and P gowns randomly and alternatively switching after 10 of 21 days hospitalization (phase 1: 42 F, mean age 49.02 years, 35 female, 7 male; 84 P, mean age 48.08 years, 72 female, 12 males; phase 2: 25 F/P, P/F, or P/P, mean age 44.0 years, 24 female, 1 male). The study involved randomly selected and blinded use of hospital gown 8 h per night of either F or P fabric. The main outcome measures were changes from admission or midpoint to discharge in quantity of pain (QN), quality of pain (QL), and paracetamol use (PU). In phase 1, all three variables significantly favored F over P when using paired t test, two sample t test, Mann–Whitney, and analysis of covariance tests. QN was reduced (F = −2.03 ∓ 0.99*, P = 0.59 ∓ 0.71). QL was reduced (F = −10.64 ∓ 5.69*, P = −2.54 ∓ 3.40). PU was reduced (F = 10.69 ∓ 6.68*, P = 26.12 ∓ 9.37). In phase 2, comparing midpoint to discharge levels in the three variables again favored P/F over F/P and P/P (>0.001): QN (P/F +16.00 ∓ 8.35* F/P −13.27 ∓ 11.40), QL (P/F +8.71 ∓ 4.75* F/P −6.55 ∓ 5.59), and PU (F −9.29 ∓ 4.39* P −18.00 ∓ 5.27) (*p = <0.001). Patients with fibromyalgia had less pain after sleeping in a gown made of Farabloc than with a placebo fabric. This suggests that Farabloc, an electromagnetic shielding fabric, has analgesic properties in fibromyalgia. Reduced pain observation is consistent with previous studies in phantom limb pain and delayed onset muscle pain. Limitations of this study include single blind design, small sample size, and in phase 2, a lack of washout period and a F/F group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Eisinger J (2003) Clinical evaluation of fibromyalgia. Rev Med Intern (4):237–242 (Apr)

    Article  Google Scholar 

  2. Henriksson KG (2003) Fibromyalgia—from syndrome to disease. Overview of pathogenic mechanisms. J Rehabil Med 41 (Suppl):89–94 (May)

    Article  Google Scholar 

  3. Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P et al (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48(5):1420–1429 (May)

    Article  PubMed  CAS  Google Scholar 

  4. Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B et al (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 25(3):188–190

    Article  PubMed  CAS  Google Scholar 

  5. Gracely RH, Grant MA, Giesecke T (2003) Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol 17(4):593–609 (Aug)

    Article  PubMed  Google Scholar 

  6. Williams DA (2003) Psychological and behavioral therapies in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol 17(4):649–665 (Aug)

    Article  PubMed  Google Scholar 

  7. Clauw DJ, Crofford LJ (2003) Chronic widespread pain and fibromyalgia; what we know and what we need to know. Best Pract Res Clin Rheumatol 17(4):685–701 (Aug)

    Article  PubMed  Google Scholar 

  8. Buskila D (1999) Drug therapy. Baillieres Best Pract Res Clin Rheumatol 13(3):479–485 (Sep)

    Article  PubMed  CAS  Google Scholar 

  9. Arnold LM, Keck PE Welge JA (2000) Antidepressant treatment of fibromyalgia. Psychosomatics 41(2):104–113 (Mar–Apr)

    Article  PubMed  CAS  Google Scholar 

  10. Karjalainen K, Malmivaara A, van Tulder M, Roine R, Jauhiainen M, Hurri I et al (2000) Multidisciplinary rehabilitation for fibromyalgia and musculoskeletal pain in working adults. Cochrane Database Sys Rev 2:CD001984

    Google Scholar 

  11. Gran JT (2003) The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17(4):547–561 (Aug)

    Article  PubMed  Google Scholar 

  12. Zhang J, Clement D, Taunton J (2000) The efficacy of Farabloc, an electromagnetic shield, in attenuating delayed onset muscle soreness. Clin J Sport Med 10(1):15–21

    Article  PubMed  Google Scholar 

  13. Conine TA, Hershler C, Alexander SA, Crisp R (1993) The efficacy of Farabloc in the treatment of phantom limb pain. Can J Rehabil 6:155–161

    Google Scholar 

  14. Gran JT (2003) The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17(4):547–561 (Aug)

    Article  PubMed  Google Scholar 

  15. Pilla AA (2002) Low-intensity electromagnetic and mechanical modulation of bone growth and repair: are they equivalent? J Orthop Sci 7(3):420–428

    Article  PubMed  Google Scholar 

  16. Neumann E, Kakorian S, Toensing K (1999) Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem Bioenerg 48(1):3–16 (Feb)

    Article  PubMed  CAS  Google Scholar 

  17. Gehl J (2003) Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 177(4):437–447 (Apr)

    Article  PubMed  CAS  Google Scholar 

  18. Bordiushkov IN, Goroshinskaia IA, Frantsiiants EM, Tkacheva GN, Gorlo EI, Neskubina IV (2000) Structural–functional changes in lymphocytes and erythrocyte membranes after exposure to alternating magnetic field. Vopr Med Khim 46(1):72–80 (Jan–Feb)

    PubMed  Google Scholar 

  19. Heida T, Wagenaar JB, Rutten WL, Marani E (2002) Investigating membrane breakdown of neuronal cells exposed to nonuniform electric fields by finite-element modeling and experiments. IEEE Trans Biomed Eng 49(10):1195–1203 (Oct)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Douglas B. Clement.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bach, G.L., Clement, D.B. Efficacy of Farabloc as an analgesic in primary fibromyalgia. Clin Rheumatol 26, 405–410 (2007). https://doi.org/10.1007/s10067-006-0494-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0494-9

Keywords

Navigation